WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Corp Stock Ownership - Who owns Adaptive Biotechnologies?

Insider buying vs selling

Have Adaptive Biotechnologies Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Peter M. NeupertDirector2023-12-13100,000$0.84
$84.00kBuy
Kyle PiskelPrincipal Accounting Officer2023-11-16259$4.13
$1.07kSell
Nitin SoodChief Commercial Officer MRD2023-08-0810,550$6.54
$69.00kSell
Nitin SoodChief Commercial Officer MRD2023-08-075,652$6.78
$38.32kSell
Tycho PetersonChief Financial Officer2023-06-2070,000$8.14
$569.80kSell
Tycho PetersonChief Financial Officer2023-06-2064,961$8.14
$528.78kSell
Tycho PetersonChief Financial Officer2023-06-20134,961$7.30
$985.22kBuy
Tycho PetersonChief Financial Officer2023-06-1514,328$7.30
$104.59kBuy
Tycho PetersonChief Financial Officer2023-06-1514,328$8.53
$122.22kSell
Tycho PetersonChief Financial Officer2023-06-1555,672$8.53
$474.88kSell

1 of 3

ADPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADPT insiders and whales buy or sell their stock.

ADPT Shareholders

What type of owners hold Adaptive Biotechnologies Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Performance LLC21.36%30,993,708$124.90MInsider
Viking Global Investors LP20.67%29,993,708$120.87MInsider
Viking Global Investors LP20.67%29,993,708$120.87MInstitution
Ark Investment Management LLC8.83%12,806,513$51.61MInstitution
Vanguard Group Inc8.80%12,767,684$51.45MInstitution
David E. Goel8.48%12,310,594$49.61MInsider
Matrix Capital Management Company LP7.98%11,572,590$46.64MInstitution
Blackrock Inc7.87%11,421,554$46.03MInstitution
Nikko Asset Management Americas Inc4.49%6,511,659$26.24MInstitution
Sumitomo Mitsui Trust Holdings Inc4.49%6,511,659$26.24MInstitution

1 of 3

ADPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADPT62.47%37.53%Net SellingNet Buying
TVTX59.75%40.25%Net SellingNet Selling
TSHA69.60%15.94%Net BuyingNet Selling
LXRX20.52%79.48%Net BuyingNet Selling
PHAT60.08%39.92%Net SellingNet Selling

Adaptive Biotechnologies Stock Ownership FAQ

Who owns Adaptive Biotechnologies?

Adaptive Biotechnologies (NASDAQ: ADPT) is owned by 98.97% institutional shareholders, 59.45% Adaptive Biotechnologies insiders, and 0.00% retail investors. Viking Global Performance LLC is the largest individual Adaptive Biotechnologies shareholder, owning 30.99M shares representing 21.36% of the company. Viking Global Performance LLC's Adaptive Biotechnologies shares are currently valued at $124.90M.

If you're new to stock investing, here's how to buy Adaptive Biotechnologies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.